Repeat Treatment with ^sup 131^I-Rituximab by ProQuest

VIEWS: 13 PAGES: 1

Bishton et al. from the Peter MacCallum Cancer Centre (Melbourne, Australia) reported on June 2 ahead of print in the Annals of Oncology on a study examining the effects of a repeat radioimmunotherapy regimen with ^sup 131^I-rituximab in patients with indolent lymphoma after relapse.

More Info
To top